Skip to main content
. 2018 Dec 11;13(12):e0208922. doi: 10.1371/journal.pone.0208922

Fig 5.

Fig 5

A and B. Blocking experiments with 20 (Fig 5A) and 40 (Fig 5B) ng IFX and its CT-P13 (Inflectra) biosimilar showing the cross reactivity of ATI with its biosimilar.